HMGB1 is passively released by injured or dying cells and aggravates inflammatory processes. The release of HMGB1 and calcium overload have each been reported to be important mediators of H 2 O 2 -induced injury. However, a potential connection between these two processes remains to be elucidated. In the present study, we employed H 2 O 2 -induced hepatocytes to investigate how calcium overload takes place during cellular injury and how the extracellular release of HMGB1 is regulated by this overload. In addition, we investigated the use of 58-F, a flavanone extracted from Ophiopogon japonicus, as a potential therapeutic drug. We show that the PLCγ1-IP 3 R-SOC signalling pathway participates in the H 2 O 2 -induced disturbance of calcium homoeostasis and leads to calcium overload in hepatocytes. After a rise in intracellular calcium, two calcium-dependent enzymes, PKCα and CaMKIV, are activated and translocated from the cytoplasm to the nucleus to modify HMGB1 phosphorylation. In turn, this promotes HMGB1 translocation from the nucleus to the cytoplasm and subsequent extracellular release. 58-F effectively rescued the hepatocytes by suppressing the PLCγ1-IP 3 R-SOC signalling pathway and decreasing the calcium concentration in cells, thus reducing HMGB1 release.
INTRODUCTION
Calcium is a universal second messenger involved in a remarkably wide range of cellular processes. 1 Disordered cytosolic calcium signalling can lead to severe damage or result in cell death. 2, 3 In non-excitable cells, Ca 2+ signals are generated by the phospholipase C (PLC)-mediated hydrolysis of phosphatidylinositol bisphosphate (PIP 2 ) to yield 1,4,5-trisphosphate (IP 3 ), leading to the subsequent activation of the inositol trisphosphate receptor (IP 3 R). This mediates the release of Ca 2+ from the endoplasmic reticulum (ER), 4 followed by transmembrane Ca 2+ entry through the opening of store-operated calcium (SOC) channels. 5 SOC channels are the predominant mechanism of calcium entry in both excitable and non-excitable cells and are activated by the depletion of internal calcium stores, for example, from the ER. Upon opening, SOC channels promote calcium entry through the plasma membrane (PM), a major mechanism for Ca 2+ influx. 6, 7 So far, two major molecular components of the SOC channel signalling pathway have been identified: stromal interaction molecule 1 (STIM1) and Orai1. 8, 9 STIM1 serves as a calcium sensor that can directly bridge the ER to PM at specialized junctions, aggregating into puncta in response to calcium store depletion and triggering the activation of SOC channels located in the PM. 10 Orai1 channels comprise six monomers and are localized diffusely in the PM of resting cells. They are recruited into puncta by STIM1 through a direct interaction, opening SOC channels to mediate store-operated calcium entry (SOCE) to ensure the optimal refilling of the ER.
11,12 SOCE plays a major role in Ca 2+ influx in nonexcitable cells, including hepatocytes. 13 Patch-clamp experiments in liver cells showed that only one type of SOC channel, a highly Ca 2+ -selective channel, could be detected. 14, 15 Therefore, SOC channels are a research hotspot in the physiology and pathology of liver disease.
Hydrogen peroxide (H 2 O 2 ) is a key mediator underlying cellular oxidative stress and is involved in a wide variety of pathological processes. It can cause intracellular Ca 2+ overload in various cell types due to oxidative stress. [16] [17] [18] Therefore, any therapeutic approach that can prevent H 2 O 2 -induced intracellular Ca 2+ overload and improve intracellular Ca 2+ regulation would be beneficial for cells. On the other hand, PLCγ1, the first protein in the PLCγ1-IP 3 R-SOC Ca 2+ signalling pathway, is upregulated as a result of H 2 O 2 -induced oxidative stress. PLC isozymes are subdivided into three types (β, γ, δ), and the γ type includes two isoforms (PLCγ1 and PLCγ2). While PLCγ1 shows a ubiquitous expression pattern, PLCγ2 is mainly expressed in B-cells. 19 Moreover, it is well established that PLCγ1 undergoes direct phosphorylation on tyrosine residues in response to H 2 O 2 treatment. 20, 21 However, to the best of our knowledge, whether PLCγ is involved in H 2 O 2 -induced Ca 2+ release in hepatocytes remains unknown.
High mobility group box 1 (HMGB1) is a highly conserved 30 kDa DNA-binding protein. In response to injury, HMGB1 is passively released from stressed cells, 22 and excessive extracellular HMGB1 adversely contributes to injury-elicited pathogenesis. 23 In the same way, HMGB1 plays a key role in various forms of liver injury. 24 The release of HMGB1 is controlled by two critical steps that regulate the flux of HMGB1 from the nucleus to the cytoplasm and subsequently from the cytoplasm to the extracellular compartment. The phosphorylation of HMGB1 at critical serine residues is essential for its translocation from the nucleus to cytoplasm. 25 The activation of two calcium-mediated protein kinases, classical protein kinase C (PKC) and Ca 2+ /calmodulindependent protein kinase IV (CaMKIV), is required for HMGB1 phosphorylation. 26, 27 PKC has many isoenzymes, and among them, PKCα is involved in HMGB1 release. 26 CaMKs are a family of proteins comprising CaMK I-IV. Activation typically requires Ca 2+ /calmodulin binding and can be augmented or sustained by phosphorylation. The identity of the specific CaMK family members involved in hypoxia-induced HMGB1 release is uncertain, but H 2 O 2 treatment has been shown to activate CaMKIV in hepatocytes. 28 In the present report, we employed these two calcium-dependent enzymes to determine whether they participate in HMGB1 phosphorylation associated with secretion.
Oxidative stress sensitizes hepatocytes to either calcium overload 29 or HMGB1 release. 30 Although HMGB1 and calcium have been separately reported to be important mediators of oxidative stress-induced injury, the potential relationship between them remains unknown. Here, we evaluate the hypothesis that SOCE activation causes calcium influx leading to calcium overload after H 2 O 2 treatment, followed by the activation of PKCα and CaMKIV and HMGB1 release in hepatocytes. Our findings support this hypothesis, demonstrating that SOCE activation leads to a cytosolic calcium increase and HMGB1 release from cells after H 2 O 2 treatment. In addition, the compound 5,8-dimethoxy-6-methyl-7-hydroxy-3-3(2-hydroxy-4-methoxybenzyl) chroman-4-one (58-F) is a flavanone extracted from Ophiopogon japonicas, which has been widely distributed and used clinically in mainland China, 29, 31 and we recently reported that 58-F protects against ROS-induced liver injury. 32 In the present study, we explore the protective contribution of 58-F to H 2 O 2 -induced calcium homoeostasis and HMGB1 release.
RESULTS
Release of HMGB1 following H 2 O 2 -induced hepatocyte injury/ death is involved in calcium entry Our previous studies found that H 2 O 2 could induce apoptosis by disrupting cellular calcium homoeostasis. 33 To confirm the effect of H 2 O 2 on cell injury/death, we examined the release of lactate dehydrogenase (LDH) from cells to media as well as the levels of HMGB1 in the media, cytosol and nucleus. After incubation with 500 μM H 2 O 2 for varying times, the levels of LDH in the cellular media increased approximately 2.5 and 3-fold at 8 and 12 h, respectively ( Figure 1a ). HMGB1 is passively released to the extracellular space upon cellular injury/death by almost all cells that have a nucleus, and it acts as a signal to neighbouring cells of ongoing damage. 23 Moreover, 500 μM H 2 O 2 led to an increase in HMGB1 release into the media (Figure 1b) , and western blot analysis of cytosolic and nuclear lysates revealed that the amount of HMGB1 protein progressively increased in the cytosol and decreased in the nucleus after H 2 O 2 treatment (Figures 1c and d) . Pretreatment with 100 μg/ml N-acetylcysteine (NAC), a common antioxidant, decreased the content of HMGB1 in the media (Figure 1b) . However, HMGB1 levels in the cytosol and nucleus continued to trend the same way with or without the antioxidant (Figures 1e and f) . Further, we tested the effects of calcium signalling pathway inhibitors on HMGB1 release. HMGB1 levels in the cellular media induced by H 2 O 2 exposure were markedly reduced by pretreatment with 10 μM U73122 (a PLC inhibitor) or 50 μM 2-APB (an IP 3 R inhibitor) (Figure 1b) . These findings indicate that cellular injury or death caused by H 2 O 2 leads to the release of HMGB1 and that this process is regulated by a calcium signalling pathway. transients in the cytoplasm, due to calcium release from intracellular store(s) for example, from the ER (Figure 2a) . After replacing the extracellular medium with a 2 mM calcium chloride solution, an increase in the heights of the right peaks representing Ca 2+ transients in the cytoplasm from media were observed (Figure 2a) , indicating extracellular calcium influx through the PM due to the depletion of ER stores. Furthermore, NAC was used to assess whether the calcium influx was caused by oxidative stress, and we observed a significant reduction of H 2 O 2 -induced left and right peaks after NAC pretreatment (Figures 2c and d) .
To investigate the possible involvement of PLC in H 2 O 2 -induced cytosolic calcium increases, cells were pre-treated with 10 μM U73122 before H 2 O 2 addition. The two peaks representing calcium entry into the cytoplasm were significantly reduced when cells were pre-treated with U73122 before H 2 O 2 addition, revealing that PLC contributes to the cytosolic calcium increase. PLC is known to stimulate IP 3 R in the ER membrane through the synthesis of IP 3 . Thus, to determine whether this pathway is important for H 2 O 2 -induced calcium increase, cells were pre-incubated with 50 μM 2-APB (an IP 3 R inhibitor), which also led to significantly reduced H 2 O 2 -induced cytosolic calcium (Figures 2e and f) . In addition, we assessed the role of SOC channels in this calcium influx by knocking down STIM1 with shRNA (Figures 2i and j) . si-STIM1 inhibited the elevation of the right peak but not the left peak of calcium influx, indicating that SOC channels affect extracellular calcium influx without altering ER Ca 2+ store release (Figures 2g and h) . Together, these results support the notion that PLC induces a signalling cascade through IP 3 and the subsequent stimulation of SOC channels to mediate H 2 O 2 -induced cytosol calcium increase.
To further validate proteomic changes that might be responsible for the H 2 O 2 -induced cytosolic calcium increase, the levels of some related proteins were assessed via western blot. Cells were exposed to H 2 O 2 at concentrations of 100, 500 or 1000 μM for 4 h or 500 μM for 1, 2, 3 or 4 h. The results revealed that both STIM1 and Orai1 protein levels increased in a H 2 O 2 concentration-and time-dependent manner (Figures 3a-d) . Furthermore, NAC and 2-APB reversed this H 2 O 2 -induced increase in STIM1 and Orai1 levels (Figures 3e-h ).
Because the PLC-IP 3 R pathway triggers SOC channels, we tested the levels of phosphorylated and total PLCγ1 after H 2 O 2 treatment. Our results showed that H 2 O 2 did not stimulate an increase in total PLCγ1 protein, but the levels of phosphorylated protein increased. These changes were significantly attenuated by the PLCγ1 inhibitor U73122 (Figures 3i and j) . It is reported that PKCα and CaMKIV are involved in HMGB1 phosphorylation and release. 26, 34 To elucidate whether HMGB1 release from hepatocytes under oxidative stress is also dependent on these kinases, we examined changes in nuclear PKCα and CaMKIV levels and their interaction with HMGB1 after H 2 (a) The cells were stimulated with 500 μM and 1 mM H 2 O 2 in Ca 2+ -free buffer, followed by the addition of 2 mM CaCl 2 to the medium. (c) The cells were pre-treated with 100 μg/ml NAC for 24 h, followed by stimulation with 500 μM H 2 O 2 and the subsequent addition of 2 mM CaCl 2 to the medium. (e) The cells were pre-treated with 50 μM 2-APB or 10 μM U73122 for 24 h, followed by stimulation with 500 μM H 2 O 2 and the subsequent addition of 2 mM extracellular Ca Owing to the calcium-dependence of PKCα and CaMKIV activity, we also measured the role of A23187 in the interactions of PKCα and CaMKIV with HMGB1. The results showed that the nuclear levels of PKCα increased at 0.5 and 1 h but decreased at 2-3 h after A23187 treatment. Additionally, the levels of CaMKIV increased at 0.5-2 h and went down at 3 h after A23187 treatment. This indicates that both kinases are induced by A23187 treatment but that CaMKIV induction persists longer than PKCα induction (Figures 6d and e) . To observe whether the interactions of PKCα or CaMKIV with HMGB1 in the nucleus are also regulated by calcium, nuclear extracts isolated from cells treated with or without A23187 were immunoprecipitated with anti-HMGB1. Both PKCα and CaMKIV could be observed in the resulting western blot (Figure 6f ). These results suggest that PKCα and CaMKIV directly bind to HMGB1 in A23187-treated cells. Cells were pre-treated with 100 μg/ml NAC (e and f) or 50 μM 2-APB (g and h) or 10 μM U73122 (i and j) for 21 h, then co-incubated with 500 μM H 2 O 2 for 3 h. PLCγ1 and p-PLCγ1 were detected by western blot. Shown are representative results from one of three independent experiments. *P o0.05, **P o0.01, ***Po0. influx by 58-F is at least partly due to the suppression of the PLCγ1-IP 3 R-SOC signalling pathway. The level of calcium entry into cells with or without 58-F pretreatment was detected by calcium imaging and confocal microscopy. In agreement with Figure 2 , the stimulation of hepatocytes with 500 μM H 2 O 2 in a calcium-free buffer led to an increase in cytosolic calcium due to the release of calcium from ER stores. After replacing the extracellular medium with a 2 mM CaCl 2 solution, a further increase in cytosolic calcium through the PM was apparent, due to the depletion of ER stores. Notably, the fluorescence intensity after adding H 2 O 2 and CaCl 2 was attenuated by pretreatment with 50 or 100 μM 58-F (Figures 7a and b) .
To assess the effects of 58-F on the protein levels of members of the PLCγ1-IP 3 R-SOC signalling pathway, we measured the levels of STIM1, Orai1, PLCγ1 and p-PLCγ1 following treatment. The H 2 O 2 -induced increased levels of both STIM1 and Orai1 were reduced by pretreatment with 58-F at concentrations ranging from 10 to 100 μM or by pretreatment with 50 μM 58-F for different periods of time (24, 48 or 72 h) (Figures 7c-f) . Furthermore, similar to the effects observed with U73122, 58-F significantly attenuated the increased levels of p-PLCγ1 induced by H 2 O 2 without affecting the levels of total PLCγ1 (Figures 7g and h ). These findings suggest that 58-F suppresses the H 2 O 2 -induced [Ca 2+ ] i increase through PLCγ1-mediated SOC channels.
Effects of 58-F on the translocation and release of HMGB1 induced by H 2 O 2 To confirm the cellular protective effect of 58-F, we examined the release of LDH from cells to media and the levels of HMGB1 in the media, cytosol and nucleus. The extracellular release of both LDH The rate of cell injury assessed using the Cytotoxicity LDH Assay Kit. Shown are representative results from one of three independent experiments. *Po0.05, **P o0.01, ***P o0.001, compared with the control; # P o0.05, compared with the 25 μM A23187-treated group; && P o0.01, compared with the 50 μM A23187-treated group. (Figures 8a and b) . Additionally, the translocation of HMGB1 from the nucleus to the cytosol was also suppressed in time-and dose-dependent manners (Figures 8c-f ).
Likewise, the nuclear levels of PKCα and CaMKIV in cells pretreated with 50 μM 58-F were significantly less than those in cells with a single H 2 O 2 treatment from 4 to 5 h (Figures 8g and h) . To further assess the direct interaction of PKCα or CaMKIV with HMGB1, Figure 5 . A23187-induced HMGB1 translocation and release in hepatocytes. (a and b) HMGB1 contents in culture media were determined using ELISA. (c-f) HMGB1 protein levels in cytosolic/nuclear fractions were measured by western blot. After incubation with A23187 (10, 25 or 50 μM) for 30 min followed by 24 h without A23187 (a, c and d) or 25 μM A23187 for 30 min followed by 12, 24 or 48 h without A23187 (b, e and f), the media and cells were harvested. (g) Cells were incubated with both 25 μM A23187 and 1 mM EGTA for 30 min, and HMGB1 levels were measured in culture media by ELISA. (h and i) HMGB1 levels in cytosolic/nuclear fractions were measured by western blot. Shown are representative results from one of three independent experiments. *Po 0.05, **Po 0.01, ***P o0.001, compared with the control; 20, 21 Under either physiological or pathological conditions, the activation of the PLCγ1 pathway produces IP 3 , which binds to its receptor IP 3 R in the ER and mobilizes Ca 2+ out of ER. Subsequently, SOC channels are activated, leading to Ca 2+ influx and the replenishing of ER stores. In our study, the role of PLCγ1-IP 3 R signalling in SOC was examined, and the results showed that H 2 O 2 -induced elevated [Ca 2+ ] i was almost abolished and that the increased phosphorylation of PLCγ1 was reduced when cells were pre-treated with the generic PLC inhibitor U73122 or the IP 3 R inhibitor 2-APB. These findings are in agreement with earlier publications reporting that the phosphorylation and activation of PLC by a sulfhydryl oxidation-dependent mechanism, which leads to increased IP 3 synthesis and subsequent activation of the IP 3 receptor, induces the release of Ca 2+ from intracellular stores 37, 38 and that the HMGB1 release by H 2 O 2 P Zhao et al noninfectious inflammation. 24 The passive release of HMGB1 from dead/stressed cells is due to its export from the nucleus to the cytoplasm and subsequent release into the extracellular space due to increased cell membrane permeability. 23 , 42 Youn and co-workers 43 and Tsung Allan et al. 28 have reported that HMGB1 release can be induced by A23187 in murine hepatocytes or in RAW264.7 cells and that this release is reduced by BAPTA, a chelator of Ca 2+ , indicating that Ca 2+ plays a critical role in oxidative stress-induced HMGB1 release. Our results show that both HMGB1 and LDH contents in the media increased after H 2 O 2 treatment and that HMGB1 levels in the media induced by H 2 O 2 exposure are markedly reduced by pretreatment with either the antioxidant NAC or the calcium pathway inhibitors 2-APB or U73122. This confirms the finding that HMGB1 release from stressed/dead cells due to oxidative stress is regulated by calcium homoeostasis. To further verify the possibility that Ca 2+ overload in the cytosol due to oxidative stress leads to HMGB1 release, we employed the calcium ionophore A23187. Our data show that increasing intracellular levels of calcium with A23187 results in the translocation of HMGB1 from the nucleus to the cytosol and its release to the extracellular space, which was markedly reduced by treatment with the calcium chelator EGTA. Phosphorylation of serine residues within the HMGB1 nuclear localization signal may also contribute to the regulation of HMGB1 cytoplasmic translocation, which is a key step for its release into the extracellular space. 22, 25 Two calcium-dependent kinases, CaMKIV and PKCα, have been implicated in the regulation of HMGB1 phosphorylation and release. 27, 43 Signalling events upstream of PKCα and CaMKIV include Ca 2+ release from the ER. We noted an increase in the levels of both PKCα and CaMKIV within the nucleus and an enhancement of their direct interaction with HMGB1 after A23187 stimulation. This is consistent with the results of H 2 O 2 treatment, supporting the view that the H 2 O 2 -mediated increase in cytoplasmic Ca 2+ is sufficient to activate CaMKIV and PKCα nuclear translocation and HMGB1 phosphorylation.
58-F intervention regulates intracellular calcium and reduces the release of HMGB1 induced by H 2 O 2 Accumulating evidence directly implicates HMGB1 in various diseases, and it has been considered as a therapeutic target for sterile inflammation and infection. 44 We recently reported that 58-F protected against ROS-induced liver injury, but the mechanism was still to be elicited. The results reported in this work indicate that 58-F inhibits calcium entry through SOC channels triggered by the PLCγ1-IP 3 R signalling pathway in response to oxidative damage. We also showed that 58-F suppresses HMGB1 translocation from the nucleus to the cytoplasm and its eventual extracellular release by inhibiting the activation of PKCα and CaMKIV.
CONCLUSION
In summary (Figure 9 ), we determined the role of the PLCγ1-IP 3 R-SOC signalling pathway in the regulation of calcium influx in cells undergoing oxidative stress and identified calcium homoeostasis in hepatocytes as a key mechanism regulating HMGB1 translocation from the nucleus to the cytoplasm for extracellular release. Our data further support the idea that calcium-dependent kinases PKCα and CaMKIV participate in HMGB1 phosphorylation, a key step leading to HMGB1 release. On the basis of these findings, 58-F, a flavanone extracted from O. japonicus, was shown to interfere with calcium overload caused by the response of the PLCγ1-IP 3 R-SOC signalling pathway to oxidative stress and with the PKCα-and CaMKIV-mediated regulation of HMGB1 release. These findings may be important for designing therapies to prevent hepatocytes from oxidative stress-induced injury/death.
MATERIALS AND METHODS

Drugs and reagents
Thirty percent H 2 O 2 was purchased from Sinopharm Chemical Reagent Co. (Shanghai, China). 58-F was purchased from Shanghai Yilin Biotechnology Co., Ltd (Shanghai, China). A23187 was purchased from Abcam (Cambridge, MA, USA). 2-Aminoethoxydiphenyl borate(2-APB) and NAC were purchased from Sigma (St. Louis, MO, USA). EGTA was purchased from Amresco (Solon, OH, USA). U73122 was purchased from Selleck (Houston, TX, USA). Dulbecco's modified Eagle's medium (DMEM), fetal calf serum (FBS) and penicillin-streptomycin were purchased from Gibco (Carlsbad, CA, USA). Hanks and D-Hanks were purchased from Gino Biological Pharmaceutical Co., Ltd (Hangzhou, China). Fluo-4/AM, Pluronic F-127 and Cytotoxicity LDH Assay Kit were purchased from Dojindo (Kumamoto, Japan). Rabbit anti-rat antibodies against STIM1, PLCγ1, p-PLCγ1, GAPDH, β-actin were purchased from Santa Cruz Biotechnology (Dallas, TX, USA); Orai1, HMGB1, PKCα, CaMKIV, Histone H3 were purchased from Abcam. Goat anti-rabbit horseradish peroxidase-conjugated secondary antibody was purchased from Shanghai Excell Biotechnology Co., Ltd (Shanghai, China). The BCA Figure 9 . HMGB1 release regulated by the PLCγ1-IP 3 R-SOC signalling pathway during calcium overload in hepatocytes. The proposed model showing the release of HMGB1 following H 2 O 2 treatment. H 2 O 2 activates the PLCγ1-IP 3 R-SOC signalling pathway, leading to calcium influx and the activation of calcium-dependent kinases PKCα and CAMKIV and triggering HMGB1 phosphorylation. Phosphorylated HMGB1 translocates from the nucleus to the cytoplasm and is ultimately released into the extracellular space.
HMGB1 release by H 2 O 2 P Zhao et al protein assay kit, SDS-PAGE and Protein A agarose were purchased from (Shanghai, China). Enhanced chemiluminescence detection system was purchased from Millipore (Billerica, MA, USA). The HMGB1 enzyme-linked immunosorbent assay (ELISA) kit was purchased from Chondrex (Redmond, WA, USA). Nuclear and cytoplasmic extraction reagents was purchased from Shanghai Yisheng Biotechnology Co., Ltd (Shanghai, China).
Cellular culture and treatment BNL.Cl 2 cells were cultured in DMEM medium supplemented with 10% FBS, 1% penicillin and streptomycin at 37°C with 5% CO 2 , and the culture media were changed once every 2 days. At 80-90% confluence, cells were treated with various agents in medium with 2% FBS. For H 2 O 2 treatment, cells were incubated with 100 μM, 500 μM or 1 mM H 2 O 2 for 1, 2, 3 or 4 h. For NAC treatment, cells were pre-treated with 100 μg/ml NAC for 24 h. For inhibition experiments, the cells were pre-treated with 50 μM 2-APB or 10 μM U73122 for 24 h and then co-treated with 500 μM H 2 O 2 for 3 h. For RNAi experiments, cells were transfected with NC-siRNA or STIM1-siRNA. For A23187 treatment, cells were treated with 10, 25 or 50 μM A23187 for 30 min; then, the medium was replaced with new DMEM with 2% FBS for 12, 24 or 48 h. Cells were co-treated with 25 μM A23187 and EGTA (25 μM) for 30 min. For 58-F administration, the cells were pre-treated with 58-F at 10, 50 or 100 μM for 24, 48 or 72 h and then exposed to 500 μM H 2 O 2 for 3 h. LDH cytotoxicity assay LDH release, which could reflect cell membrane integrity, was detected with an assay kit (Dojindo) according to the manufacturer's instructions. Briefly, cells were cultured in 96-well microplates (7 × 10 3 cells/well) for 24 h in a CO 2 incubator and then incubated with different treatments. First, 10 μl of Lysis Buffer was added to the well to induce maximum LDH release. After 30 min in a CO 2 incubator, 100 μl of Working Solution was added into each well, and the plates were incubated in darkness at room temperature for 30 min. Subsequently, 50 μl of Stop Solution was added to each well, and the absorbance was measured at 490 nm using a microplate reader. The calculation was as follows: LDH release (%) = [A-C/B-C] × 100%, where A is the absorbance of treated samples, and B and C are the absorbance of the maximum and the minimum, respectively.
Measurement of intracellular
ELISA assay
The cell culture medium was collected and used to measure HMGB1 levels by ELISA kits according to the manufacturer's suggested protocol. Absorbance at 450 nm was measured using a microplate reader.
Preparation of cell extracts
Nuclear and cytosolic extracts were prepared using nuclear and cytoplasmic extraction reagents, according to the manufacturer's instructions. The total protein extract was lysed in RIPA buffer and phenylmethylsulfonyl fluoride. The protein concentrations were determined by bicinchoninic acid assay.
Western blot analysis
Equal amounts of total cellular protein (20 μg per sample) were separated by SDS-PAGE and transferred to PVDF membranes that were blocked with 5% non-fat milk for 2 h and incubated with the primary antibodies overnight at 4°C. The primary antibodies (diluted at 1 : 1000) used were as follows: anti-STIM1, anti-Orai1, anti-PLCγ1, anti-p-PLCγ1, anti-HMGB1, anti-PKCα, anti-CaMKIV anti-GAPDH, anti-β-actin, and anti-Histone H3 (1 : 500). The membranes were then washed three times (10 min/wash) with TBST and incubated with a 1 : 3000 dilution of goat anti-rabbit horseradish peroxidase-conjugated secondary antibody for 1 h at room temperature. After the final wash, the immunoreactive bands were detected on Fluor Chem E (Protein Simple) by enhanced chemiluminescence. The densities of bands were analysed using ImageJ software and expressed as ratios to β-actin or GAPDH or Histone H3.
Immunoprecipitation
A total of 500 μg of nuclear extract was incubated with 2 μg of anti-HMGB1 at 4°C overnight on a rotator. Next, 30 μl of Protein A Agarose was spun briefly in a microcentrifuge at 500 g for 30 s and washed three times in PBS, then resuspended in 200 μl of PBS. A 40 μl slurry of Protein A agarose was added to each sample, followed by incubation for an additional 3 h at 4°C on a rotator. The samples were spun briefly in a microcentrifuge at 500 g for 2 min and washed three times in PBS. Finally, the samples were resuspended in 40 μl of loading buffer for future analysis.
RNAi
We utilized the Smartpool siRNA from Dharmacon (Lafayette, CO, USA) that consists of four separate siRNA sequences against STIM1: GCGACTTCT GAAGAGTCTACC, GCTGCTGGTTTGCCTATATCC, GCGGTTTCCAGATTGTCA ATA and GGATTTGACCCATTCCGATTC, and a control siRNA NC: TTCTCCGA ACGTGTCACGT. The LV3(H1/RFG&Puro)-STIM1 and NC constructs were constructed and identified by Shanghai UsenLab Biotechnology Co., Ltd. (Shanghai, China). Cells were plated in a six-well plate or confocal dish in 10% DMEM without antibiotics, resulting in 80% confluence before transfection. In separate tubes, 1.5 μg of each plasmid was diluted in 250 μl serum-free DMEM. Each solution was combined with 5 μl of Lipofectamine 2000 and mixed gently, and the final transfection mixture was incubated for 20 min at room temperature. The cells were transfected with STIM1-siRNA or NC-siRNA according to the manufacturer's protocol (Invitrogen, Carlsbad, CA, USA). Transfection efficiency was determined at 24 h by fluorescence microscopy, and mRNA and protein expression levels were measured 48 h after transfection.
Statistical analysis
Experiments were carried out in triplicate, and statistical analysis was performed using SPSS software. Significance between two groups was assessed using the paired or non-paired Student's t-test (t-test), and significance among multiple groups was assessed using a one-factor analysis of variance (ANOVA) with the Dunnett's post hoc test. Po 0.05 was considered as a statistically significant difference.
